Akari Therapeutics Plc Sponsored ADRAkari Therapeutics Plc Sponsored ADRAkari Therapeutics Plc Sponsored ADR

Akari Therapeutics Plc Sponsored ADR

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪8.61 M‬USD
‪−19.80 M‬USD
0.00USD
‪32.48 M‬
Beta (1Y)
0.62

About Akari Therapeutics Plc Sponsored ADR


CEO
Abizer Gaslightwala
Headquarters
Tampa
Founded
2004
Identifiers
3
ISINUS00972G2075
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Check out other big names from the same industry as AKTX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.